chr1-152351437-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001014342.3(FLG2):āc.6349G>Cā(p.Val2117Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000141 in 1,612,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2117A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001014342.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FLG2 | NM_001014342.3 | c.6349G>C | p.Val2117Leu | missense_variant | 3/3 | ENST00000388718.5 | |
FLG-AS1 | NR_103778.1 | n.1406+10227C>G | intron_variant, non_coding_transcript_variant | ||||
FLG-AS1 | NR_103779.1 | n.151+10227C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FLG2 | ENST00000388718.5 | c.6349G>C | p.Val2117Leu | missense_variant | 3/3 | 5 | NM_001014342.3 | P1 | |
FLG-AS1 | ENST00000653548.1 | n.757+13348C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 151274Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251388Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135856
GnomAD4 exome AF: 0.000152 AC: 222AN: 1461636Hom.: 0 Cov.: 36 AF XY: 0.000135 AC XY: 98AN XY: 727134
GnomAD4 genome AF: 0.0000331 AC: 5AN: 151274Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73844
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.6349G>C (p.V2117L) alteration is located in exon 3 (coding exon 2) of the FLG2 gene. This alteration results from a G to C substitution at nucleotide position 6349, causing the valine (V) at amino acid position 2117 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at